Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FLGNY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,366
Award facts
- Contract value 100% obligated
- $23,366.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On August 22, 2025, the Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $23,366.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, numbered 4569186045, calls for the supply of 60 tablets of Xtandi 80 mg, an oncology medication used in the treatment of prostate cancer. This award represents a single delivery order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which carries a total contract value of $499,999,999 and remains valid through November 2026. The delivery is to be completed by August 25, 2025, with no set-aside designation applied to this particular order.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively for DLA procurement opportunities. The company's core business involves distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities nationwide. Through its SPE2DB IDC with the DLA, the vendor is positioned to fulfill firm fixed-price delivery orders across an extensive portfolio of pharmaceutical items supporting medical supply needs at Department of Defense healthcare sites globally.
Quick answers
Who was awarded contract SPE2DB25FLGNY?
SPE2DB25FLGNY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FLGNY worth?
The government has obligated $23,366 on SPE2DB25FLGNY.
Is contract SPE2DB25FLGNY an order under another contract?
Yes. SPE2DB25FLGNY is a delivery order under SPE2DB24D9644, an indefinite delivery contract.
Was contract SPE2DB25FLGNY competed?
The extent of competition for SPE2DB25FLGNY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award